NLA Endorses ACC Guidance for Non-Statin Therapies

The National Lipid Association (NLA) endorses the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk, published by the American College of Cardiology on April 1 in the Journal of the American College of Cardiology. Click here to view the document.